Wanbury Ltd

NSE: WANBURY · BSE: 524212 · Pharmaceuticals & Biotechnology · 31 announcements

Wanbury Ltd news stories on ALFA NewsRead the news →

Share price: ₹198.25
Market cap: ₹693.2 Cr
Revenue (annual): ₹650.3 Cr
Net profit (annual): ₹66.13 Cr
P/E (TTM): 12.4×Sector 47.4×
Promoter holding: 43.02%+0.00% QoQ
FII holding: 0.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11 Aug 2026 21:07 IST NSE

Wanbury Results Update

Wanbury reported Q1 FY27 financial results in a press release. The company also completed a Rs. 205 crore debt refinancing, improving its borrowing profile.

Value: ₹205.0 Cr

Read the filing ↗

2 Jun 2026 12:18 IST NSE

Results Update

Wanbury Results Update

Wanbury Limited reported ₹650.3 Crore revenue for FY26, with PAT surging 117% to ₹66.1 Crore. Strong growth was driven by new API launches and improved margins.

Value: ₹650.3 Cr

Read the filing ↗